Barclays »

Quoin Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Quoin Pharmaceuticals (QNRX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Quoin Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Quoin Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quoin Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.6k 1.3k 6.60

More positions owned by Barclays

Ishares Tr Opt Put Option (EEM)
Microsoft Corporation (MSFT)
STATE STR SPDR S&ampP 500 ETF T Opt Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Opt Call Option (QQQ)
Ishares Tr Fund (IWM)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Ishares Tr Opt Put Option (HYG)
JPMORGAN CHASE &amp Opt Call Option (JPM)
Alphabet Inc Class C cs (GOOG)

View all positions for Barclays

Top funds holding Quoin Pharmaceuticals

Ikarian Capital
Dauntless Investment Group
SummitTX Capital
Velan Capital Investment Management
Woodline Partners
Millennium Management
Standard Life Aberdeen
Soleus Capital Management
Centiva Capital
Boothbay Fund Management
Stonepine Capital Management
AIGH Capital Management
Citadel Advisors
Birchview Capital
Morgan Stanley

View all funds holding Quoin Pharmaceuticals